Burleson & Co’s Enovis ENOV Stock Holding History

Burleson & Co’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22	Closed	-$1K	–	425
2022 Q2	$1K	Buy	+22	New	+$1.42K	﹤0.01%	363

Other funds holding ENOV

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Burleson & Co's ENOV Position: Q3 2022 in Review

Burleson & Co sold out of Enovis (ENOV) in Q3 2022, closing a stake of 22 shares — an estimated $1K sold.

Burleson & Co first reported a position in ENOV in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 242 funds tracked by Wall St. Rank hold ENOV as of Q3 2022.

Burleson & Co reported no remaining Enovis position as of Q3 2022 after selling out during the quarter.
Burleson & Co sold 22 Enovis shares in Q3 2022, an estimated $1K.
Burleson & Co first reported a position in Enovis in Q2 2022 and held it in 1 quarter.
Burleson & Co's Enovis position peaked at $1K in Q2 2022.
242 funds tracked by Wall St. Rank held Enovis as of Q3 2022.

Based on Burleson & Co's 13F filing for Q3 2022, filed 17 Oct 2022.